CMS seeks comment on proposed eRx changes

The Centers for Medicare & Medicaid Services (CMS) is asking for comments about a proposed rule that would modify certain parts of the Electronic Prescribing (eRx) Incentive Program, which uses incentive payments and payment adjustments to encourage the use of e-prescribing systems.

On May 26, CMS released a proposed rule, titled “Proposed Changes to the 2011 Electronic Prescribing Incentive Program,” to address stakeholders' concerns regarding the implementation of the 2012 eRx payment adjustment.

The proposed rule would:
1. Modify the e-prescribing measure to allow for use of certified EHR technology.

2. Provide the following additional significant hardships to the 2012 e-prescription payment adjustment:
  • Eligible professionals who register to participate in the Medicare or Medicaid EHR Incentive Program and adopt certified EHR technology;
  • Inability to e-prescribe due to local, state or federal law or regulation;
  • Limited prescribing activity; or
  • Insufficient opportunities to report the e-prescribing measure due to limitations in the measure’s denominator.

3. Allow eligible professionals until Oct. 1 to submit a request for a significant hardship exemption.

    “CMS is not currently accepting exemption requests based on the proposed significant hardship exemptions stated above. If finalized, CMS will provide instructions for submitting significant hardship requests in a final rule,” the agency stated.

    Click here to see the proposed rule. Comments will be accepted until July 25.

    Around the web

    GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

    Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

    The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.